Objective: To identify the risk factors of aromatase inhibitor( AI)-related arthralgia( AIA) for predicting the risk of AIA and improving compliance of medication. Methods: A total of 105 breast cancer patients with AI monotherapy were reviewed. We evaluated the potential clinical factors for AIA using chi-square test and the multivariate logistic regression model. We evaluated the correlation between the pain score and independent factors using the chi-square or Fisher's exact test. Results: Among 105 pati...